Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999046156> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2999046156 endingPage "1262" @default.
- W2999046156 startingPage "1257" @default.
- W2999046156 abstract "Abstract Background Epithelial surface disruption in genital psoriatic lesions may manifest as erosions, fissures and/or ulcers, causing pain and significantly impacting a patient's sexual health. Objective To evaluate the impact of erosions, fissures and/or ulcers in genital psoriatic lesions on pain and sexual activity in patients with moderate‐to‐severe genital psoriasis (GenPs) and treatment responses to ixekizumab vs. placebo until Week 12. Methods This post hoc subgroup analysis of patients presenting with and without erosions, fissures and/or ulcers in genital lesions from a phase III b multicentre, randomized, double‐blind, placebo‐controlled study ( IXORA ‐Q; NCT 02718898) in 149 adults with moderate‐to‐severe GenPs treated with subcutaneous ixekizumab (80 mg every 2 weeks; n = 75) or placebo ( n = 74) evaluated outcomes for clinician‐rated GenPs severity (static Physician's Global Assessment of Genitalia; sPGA ‐G) and patient‐reported genital pain and itch (Genital Psoriasis Symptoms Scale; GPSS ) and sexual health (Genital Psoriasis Sexual Frequency Questionnaire; GenPs‐ SFQ ). Results At baseline, 38% ( n = 57) of patients presented with genital erosions, fissures and/or ulcers independent of overall body surface area involvement (<10% or ≥10%). These signs were associated with higher scores for disease severity ( sPGA ‐G) and pain ( GPSS ) but not sexual health (GenPs‐ SFQ ). Complete resolution of these signs was observed in 62% of ixekizumab‐treated patients (25% for placebo) at Week 1 and 83% (21% for placebo) at Week 12. Patients treated with ixekizumab reported significant improvements in pain, itch, disease severity and sexual health over 12 weeks compared to placebo and irrespective of the presence/absence of genital erosions, fissures and/or ulcers at baseline. Conclusion Ixekizumab led to rapid and sustained resolution of erosions, fissures and/or ulcers and significant improvements in GenPs severity, genital pain and sexual health. Ixekizumab may help to improve the well‐being of patients with GenPs." @default.
- W2999046156 created "2020-01-23" @default.
- W2999046156 creator A5001431413 @default.
- W2999046156 creator A5012702987 @default.
- W2999046156 creator A5038781275 @default.
- W2999046156 creator A5040210846 @default.
- W2999046156 creator A5043799216 @default.
- W2999046156 creator A5047076464 @default.
- W2999046156 creator A5072327100 @default.
- W2999046156 date "2020-02-05" @default.
- W2999046156 modified "2023-09-26" @default.
- W2999046156 title "Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis" @default.
- W2999046156 cites W1675708284 @default.
- W2999046156 cites W1985969803 @default.
- W2999046156 cites W2007090120 @default.
- W2999046156 cites W2060078400 @default.
- W2999046156 cites W2088640486 @default.
- W2999046156 cites W2096991001 @default.
- W2999046156 cites W2097170399 @default.
- W2999046156 cites W2099181231 @default.
- W2999046156 cites W2121023063 @default.
- W2999046156 cites W2170135921 @default.
- W2999046156 cites W2397615067 @default.
- W2999046156 cites W2615427840 @default.
- W2999046156 cites W2766193813 @default.
- W2999046156 cites W2774443073 @default.
- W2999046156 cites W2774683544 @default.
- W2999046156 cites W2802931074 @default.
- W2999046156 cites W2888197065 @default.
- W2999046156 cites W2891858343 @default.
- W2999046156 doi "https://doi.org/10.1111/jdv.16181" @default.
- W2999046156 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7318177" @default.
- W2999046156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31919919" @default.
- W2999046156 hasPublicationYear "2020" @default.
- W2999046156 type Work @default.
- W2999046156 sameAs 2999046156 @default.
- W2999046156 citedByCount "11" @default.
- W2999046156 countsByYear W29990461562020 @default.
- W2999046156 countsByYear W29990461562021 @default.
- W2999046156 countsByYear W29990461562022 @default.
- W2999046156 countsByYear W29990461562023 @default.
- W2999046156 crossrefType "journal-article" @default.
- W2999046156 hasAuthorship W2999046156A5001431413 @default.
- W2999046156 hasAuthorship W2999046156A5012702987 @default.
- W2999046156 hasAuthorship W2999046156A5038781275 @default.
- W2999046156 hasAuthorship W2999046156A5040210846 @default.
- W2999046156 hasAuthorship W2999046156A5043799216 @default.
- W2999046156 hasAuthorship W2999046156A5047076464 @default.
- W2999046156 hasAuthorship W2999046156A5072327100 @default.
- W2999046156 hasBestOaLocation W29990461561 @default.
- W2999046156 hasConcept C126322002 @default.
- W2999046156 hasConcept C142724271 @default.
- W2999046156 hasConcept C16005928 @default.
- W2999046156 hasConcept C183021626 @default.
- W2999046156 hasConcept C204787440 @default.
- W2999046156 hasConcept C27081682 @default.
- W2999046156 hasConcept C2776260265 @default.
- W2999046156 hasConcept C2779745271 @default.
- W2999046156 hasConcept C2779786854 @default.
- W2999046156 hasConcept C2780564577 @default.
- W2999046156 hasConcept C54355233 @default.
- W2999046156 hasConcept C71924100 @default.
- W2999046156 hasConcept C86803240 @default.
- W2999046156 hasConceptScore W2999046156C126322002 @default.
- W2999046156 hasConceptScore W2999046156C142724271 @default.
- W2999046156 hasConceptScore W2999046156C16005928 @default.
- W2999046156 hasConceptScore W2999046156C183021626 @default.
- W2999046156 hasConceptScore W2999046156C204787440 @default.
- W2999046156 hasConceptScore W2999046156C27081682 @default.
- W2999046156 hasConceptScore W2999046156C2776260265 @default.
- W2999046156 hasConceptScore W2999046156C2779745271 @default.
- W2999046156 hasConceptScore W2999046156C2779786854 @default.
- W2999046156 hasConceptScore W2999046156C2780564577 @default.
- W2999046156 hasConceptScore W2999046156C54355233 @default.
- W2999046156 hasConceptScore W2999046156C71924100 @default.
- W2999046156 hasConceptScore W2999046156C86803240 @default.
- W2999046156 hasFunder F4320307758 @default.
- W2999046156 hasIssue "6" @default.
- W2999046156 hasLocation W29990461561 @default.
- W2999046156 hasLocation W29990461562 @default.
- W2999046156 hasLocation W29990461563 @default.
- W2999046156 hasOpenAccess W2999046156 @default.
- W2999046156 hasPrimaryLocation W29990461561 @default.
- W2999046156 hasRelatedWork W1842803802 @default.
- W2999046156 hasRelatedWork W2088640486 @default.
- W2999046156 hasRelatedWork W2170135921 @default.
- W2999046156 hasRelatedWork W2234466474 @default.
- W2999046156 hasRelatedWork W2897210759 @default.
- W2999046156 hasRelatedWork W2904527393 @default.
- W2999046156 hasRelatedWork W2943840466 @default.
- W2999046156 hasRelatedWork W3080588810 @default.
- W2999046156 hasRelatedWork W3212484138 @default.
- W2999046156 hasRelatedWork W4281753350 @default.
- W2999046156 hasVolume "34" @default.
- W2999046156 isParatext "false" @default.
- W2999046156 isRetracted "false" @default.
- W2999046156 magId "2999046156" @default.
- W2999046156 workType "article" @default.